CRISPR Therapeutics AG
MATERIALS AND METHODS FOR CONTROLLING GENE EDITING
Last updated:
Abstract:
The present application provides materials and methods for controlling gene editing. The present application also provides materials and methods for controlling transcriptional expression of guide RNAs and/or post-transcriptional expression of Cas nuclease.
Status:
Application
Type:
Utility
Filling date:
26 Jun 2020
Issue date:
31 Dec 2020